triamcinolone acetonide has been researched along with Vitreoretinopathy, Proliferative in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 11 (45.83) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, D; Boral, SK; Chakraborty, D; Das, A | 1 |
| Anthony, B; Banerjee, P; Bunce, C; Casswell, E; Charteris, DG; Cornelius, VR; Cro, S; Edwards, RT; Ezeofor, V; Kelly, J; Murphy, C; Robertson, E | 1 |
| Busquets, MA; Lutz, CT; Zhao, T | 1 |
| Bian, C; Chen, M; Cheng, L; Jin, Y; Li, X; Shen, Y; Wu, S; Yang, J | 1 |
| Erdiakov, AK; Gavrilova, SA; Tikhonovich, MV | 1 |
| Banerjee, PJ; Bunce, C; Charteris, DG; Scott, R; Woodcock, MG | 1 |
| Avitabile, T; Gagliano, C; Stella, S; Toro, MD; Uva, MG | 1 |
| Banerjee, PJ; Bunce, C; Charteris, DG; Cornelius, VR; Edwards, RT; Kelly, J; Lo, JW; Murphy, C; Phillips, R; Robertson, EL | 1 |
| Banerjee, P; Bunce, C; Charteris, D; Cornelius, VR; Lo, JW; Phillips, R | 1 |
| Ahmadieh, H; Feghhi, M; Mohebbi, MR; Ramezani, A; Shoeibi, N; Tabatabaei, H | 1 |
| Farah, ME; Maia, M; Rodrigues, EB | 1 |
| Acar, N; Altan, T; Kapran, Z; Pasaoglu, E; Unver, YB | 1 |
| Chen, H; Chen, W; Fok, A; Hou, P; Hu, Y; Lam, DS | 1 |
| Kang, S; Lee, Y; Park, YH | 1 |
| Jonas, JB | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I | 1 |
| Degenring, R; Jonas, JB; Söfker, A | 1 |
| Enaida, H; Ishibashi, T; Kawano, YI; Kubota, T; Nakamura, T; Sakamoto, T; Sonoda, KH; Ueno, A | 1 |
| Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU | 1 |
| Degenring, RF; Hayler, J; Jonas, JB; Söfker, A | 1 |
| Boscia, F; Cardascia, N; Furino, C; Micelli Ferrari, T; Recchimurzo, N; Sborgia, C | 1 |
| Buerk, BM; Munir, WM; Pulido, JS; Sharma, MC | 1 |
| Furukawa, M; Ishibashi, T; Kubota, T; Nakahara, M; Noda, Y; Ogino, N; Sakamoto, T; Yamakiri, K; Yokoyama, M | 1 |
| Cai, YS; Hui, YN; Liang, HC | 1 |
4 review(s) available for triamcinolone acetonide and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Intravitreal Steroids for the Prevention of PVR After Surgery for Retinal Detachment.
Topics: Anti-Inflammatory Agents; Cell Proliferation; Dexamethasone; Humans; Intravitreal Injections; Ophthalmologic Surgical Procedures; Retinal Detachment; Risk Factors; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative | 2015 |
Dyes in ocular surgery: principles for use in chromovitrectomy.
Topics: Benzenesulfonates; Coloring Agents; Epiretinal Membrane; Humans; Indocyanine Green; Macular Edema; Retinal Perforations; Rosaniline Dyes; Staining and Labeling; Triamcinolone Acetonide; Trypan Blue; Vitrectomy; Vitreoretinopathy, Proliferative | 2009 |
[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Retinal Neovascularization; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
[Diabetic maculopathy - classification and therapy].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Injections; Laser Coagulation; Macular Edema; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
7 trial(s) available for triamcinolone acetonide and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.
Topics: Glucocorticoids; Humans; Quality of Life; Retinal Detachment; Triamcinolone Acetonide; Vitreoretinal Surgery; Vitreoretinopathy, Proliferative | 2023 |
A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protocol f
Topics: Administration, Ophthalmic; Administration, Oral; Anti-Inflammatory Agents; Clinical Protocols; Drug Therapy, Combination; Eye Injuries; Flurbiprofen; Glucocorticoids; Humans; London; Ophthalmic Solutions; Pilot Projects; Prednisolone; Research Design; Single-Blind Method; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreoretinal Surgery; Vitreoretinopathy, Proliferative | 2013 |
Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled tr
Topics: Administration, Ophthalmic; Chemotherapy, Adjuvant; Clinical Protocols; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Eye Injuries; Glucocorticoids; Hospital Costs; Humans; Pilot Projects; Research Design; Retinal Detachment; Time Factors; Treatment Outcome; Triamcinolone Acetonide; United Kingdom; Vision, Ocular; Vitreoretinal Surgery; Vitreoretinopathy, Proliferative | 2016 |
A phase III, multi-centre, double-masked randomised controlled trial of adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): statistical
Topics: Administration, Ophthalmic; Chemotherapy, Adjuvant; Clinical Protocols; Data Interpretation, Statistical; Double-Blind Method; Eye Injuries; Glucocorticoids; Humans; Models, Statistical; Recovery of Function; Research Design; Time Factors; Treatment Outcome; Triamcinolone Acetonide; United Kingdom; Visual Acuity; Vitrectomy; Vitreoretinal Surgery; Vitreoretinopathy, Proliferative | 2016 |
Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Topics: Combined Modality Therapy; Female; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Retinal Detachment; Silicone Oils; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2008 |
Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy.
Topics: Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraoperative Care; Male; Middle Aged; Postoperative Complications; Prospective Studies; Retinal Detachment; Single-Blind Method; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2008 |
13 other study(ies) available for triamcinolone acetonide and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Complete manuscript title: role of sub-silicone oil application of triamcinolone acetonide (TA) drops on outcomes after 360° relaxing retinectomy: a pilot study.
Topics: Humans; Pilot Projects; Retinal Detachment; Retrospective Studies; Silicone Oils; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2023 |
Management of Cystoid Macular Edema After Vitrectomy for Proliferative Vitreoretinopathy.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Disease Management; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2020 |
Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.
Topics: Animals; Delayed-Action Preparations; Eye Injuries; Rabbits; Sclera; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative | 2021 |
Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Concanavalin A; Disease Models, Animal; Intravitreal Injections; Piroxicam; Rats; Rats, Wistar; Retina; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body | 2018 |
Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy.
Topics: Adult; Aged; Epiretinal Membrane; Female; Fluorocarbons; Follow-Up Studies; Glucocorticoids; Humans; Intraoperative Complications; Laser Coagulation; Male; Middle Aged; Postoperative Complications; Pseudophakia; Recurrence; Retinal Detachment; Retrospective Studies; Silicone Oils; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2010 |
Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy.
Topics: Adult; Aged; Drainage; Endotamponade; Female; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Silicone Oils; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body; Young Adult | 2011 |
Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.
Topics: Diabetic Retinopathy; Female; Gases; Glucocorticoids; Humans; Injections; Male; Middle Aged; Tenon Capsule; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2013 |
Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil.
Topics: Female; Glucocorticoids; Humans; Male; Middle Aged; Postoperative Period; Silicone Oils; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative | 2002 |
Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
Topics: Adult; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2003 |
Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?
Topics: Combined Modality Therapy; Glucocorticoids; Humans; Injections; Triamcinolone Acetonide; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2003 |
Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy.
Topics: Combined Modality Therapy; Epiretinal Membrane; Female; Fluorocarbons; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Pseudophakia; Retinal Detachment; Silicone Oils; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative | 2003 |
Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Topics: Adult; Aged; Combined Modality Therapy; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Retrospective Studies; Silicone Oils; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2005 |
[Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
Topics: Animals; Female; Male; Rabbits; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative | 1994 |